Drug shortage
Bumetanide Injection · MSN Laboratories Private Limited
FDA drug shortage · Current · updated Feb 17, 2025
Key facts
| Generic name | Bumetanide Injection |
|---|---|
| Proprietary name | Bumetanide |
| Company | MSN Laboratories Private Limited |
| Presentation | Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) |
| Dosage form | Injection |
| Strength | 0.25 mg/mL, 4mL |
| Status | Current |
| Reason for shortage | Discontinuation of the manufacture of the drug |
| Therapeutic category | Cardiovascular |
| Package NDCs | 72205-101-01 |
| First posted | Dec 13, 2017 |
| Last updated | Feb 17, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: